ANNX

Annexon Inc

NASDAQ: ANNX · HEALTHCARE · BIOTECHNOLOGY

$4.86

-2.21% today

Updated 2026-07-29

Market cap

$856.90M

P/E ratio

—

P/S ratio

—

EPS (TTM)

$-1.16

Dividend yield

—

52W range

$2 – $7

Volume

3.9M

Market cap

$856.90M

P/E ratio

—

P/S ratio

—

EPS (TTM)

$-1.16

Dividend yield

—

52W range

$2 – $7

Volume

3.9M

WallStSmart proprietary scores

out of 100

Grade: F

Strong Sell

Investment rating

4.3

Growth

6.0

Quality

3.0

Profitability

5.0

Valuation

C+

1/9

Piotroski F-Score

Weak

-4.3

Altman Z-Score

Distress

—

Industry rank

—

View all highly rated stocks (75+) →206 stocks currently score above 75

Price targets

Analyst target

$13.56

+179.01%

12-Month target

—

Intrinsic (DCF)

—

Margin of safety

—

2 Strong Buy7 Buy1 Hold0 Sell0 Strong Sell

Price chart

Stock snapshot

Strengths

+ Debt/equity 0.12x — low leverage

Risks

- Piotroski 1/9 — weak financial health

- Altman Z -4.30 — distress zone

- Thin margins at 0.00%

- Negative free cash flow $-46.80M

Key financials

Revenue Net Income Free Cash Flow

Metric	2022	2023	2024	2025	TTM
Revenue	$0.00	$0.00	$0.00	$0.00	$0.00
Net income	$-138.29M	$-134.24M	$-138.20M	$-206.69M	$-44.14M
EPS	—	—	—	—	$-1.16
Free cash flow	$-122.83M	$-121.33M	$-118.02M	$-186.49M	$-46.80M
Profit margin	—	—	—	—	—

Recent insider activity

Date	Insider	Type	Shares	Price
2026-06-11	YEDNOCK, TED	Sale	30,646	—
2026-06-11	YEDNOCK, TED	Buy	30,646	$1.85
2026-06-11	WADDILL, WILLIAM D.	Buy	65,000	—

Peer comparison

Company	Mkt Cap	Score	Growth	Profit	Value	Quality	MoS	Rating
ANNX	$856.90M	26	4.3	3.0	5.0	6.0	—	Avoid
LLY	$1.02T	76	10.0	10.0	4.3	6.0	—	Strong Buy
JNJ	$615.36B	57	4.7	8.5	4.3	6.0	—	Buy
ABBV	$447.53B	63	4.0	8.0	4.7	5.0	-78.83%	Buy
UNH	$391.69B	62	7.3	5.5	4.0	6.0	-30.51%	Buy
MRK	$307.25B	50	3.3	8.0	2.7	5.0	-62.28%	Hold

Smart narrative

Annexon Inc trades at $4.86. Our Smart Value Score of 26/100 indicates the stock is weak. The company scores 1/9 on the Piotroski F-Score. With an Altman Z-Score of -4.30, it sits in the distress.

Frequently asked questions

What is Annexon Inc's stock price?

Annexon Inc (ANNX) trades at $4.86.

Is Annexon Inc overvalued?

Annexon Inc carries a Smart Value Score of 26/100 (Grade F), which we rate Strong Sell. That score blends growth, quality, and valuation into one read.

What is the price target of Annexon Inc (ANNX)?

The 12-month analyst consensus target is $13.56, about 179.0% above the current $4.86. A consensus target is the average of Wall Street's 12-month forecasts, so it works as a sentiment gauge rather than a guarantee, and it resets with every earnings cycle.

Altman Z-Score?

Annexon Inc's Altman Z-Score is -4.30, which places it in the distress. The Altman Z-Score gauges bankruptcy risk from profitability, leverage, and asset efficiency, and a higher reading points to lower financial distress risk.

Company info

SectorHEALTHCARE

IndustryBIOTECHNOLOGY

CountryUSA

ExchangeNASDAQ

CurrencyUSD

Quick metrics

P/S ratio—

ROE-96.06%

Beta1.17

50D MA$5.38

200D MA$5.06

Shares out0.16B

Float0.13B

Short ratio—

Avg volume3.9M

Performance

1 week-4.97%

1 month-10.77%

3 months-15.62%

YTD-1.00%

1 year—

3 years—

5 years—

Compare

ANNX vs LLY →ANNX vs JNJ →ANNX vs ABBV →Stock screener →